Targeted Therapeutics in CLL and MCL: Applying Emerging BTK Inhibitor Therapy Data to Practice *

Get up to date on emerging data with BTK inhibitors for chronic lymphocytic leukemia and mantle cell lymphoma presented at the 2023 EHA, ICML, SOHO, and ESMO meetings with expert podcasts, downloadable slides, text modules, an infographic, and an on-demand webcast. 

Share

Program Content

Activities

Global CLL Tool
Expert Guidance for the Treatment of CLL: An International Perspective
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: February 08, 2024

Activities

Global MCL Tool
Interactive Decision Support Tool: Global MCL Expert Treatment Guidance
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: February 21, 2024

Activities

2023 BTKi Highlights in CLL and MCL
2023 Global Conference Coverage Updates on BTK Inhibitors for CLL and MCL
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2023

Activities

BTKi Therapy for CLL: EHA 2023
New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023
Conference Coverage
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 28, 2023

Activities

BTK Inhibitors in Practice
Targeted Therapeutics in CLL and MCL: Applying Emerging BTK Inhibitor Therapy Data to Practice
Conference Coverage
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2023

Expires: July 17, 2024

Activities

BTKis in CLL From EHA 2023
Key Updates With BTK Inhibitors in CLL From EHA 2023
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2023

Expires: August 09, 2024

Activities

BTKi Therapy for MCL: ICML 2023
New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023
Conference Coverage
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2023

Activities

BTKi in MCL From ICML 2023
Key Updates With BTK Inhibitors in MCL From ICML 2023
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2023

Expires: August 17, 2024

Activities

BTKi Therapy for CLL and MCL: SOHO 2023
New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023
Conference Coverage
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 04, 2023

Activities

BTKi in CLL and MCL From SOHO 2023
Key Updates With BTK Inhibitors in CLL and MCL From SOHO 2023
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 18, 2023

Expires: October 17, 2024

Activities

A Review and Look to the Future: BTKi in CLL and MCL
A Year in Review and a Look to the Future: BTKi in CLL and MCL
Conference Coverage
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2023

Activities

Review of BTKi for CLL and MCL
A Year in Review: Expert Perspectives on Current and Emerging Data With BTK Inhibitors for CLL and MCL
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2023

Expires: December 04, 2024

Activities

BTKi in CLL and MCL update
Applying Data to Practice: BTK Inhibitor Therapies to Treat CLL and MCL
Video
Congratulations: You achieved a completion on 04/09/2022

Released: January 26, 2024

Expires: January 25, 2025

Faculty

cover img faculity

Brad Kahl, MD

Professor of Medicine
Washington University School of Medicine
Director Lymphoma Program
Siteman Cancer Center
St. Louis, Missouri 

cover img faculity

Catherine C. Coombs, MD, MS

Associate Clinical Professor of Medicine
Department of Medicine
Divsion of Oncology & Hematology
University of California, Irvine
Irvine, California

cover img faculity

Florence Cymbalista, MD, PhD

Professor of Hematology
Sorbonne Paris Nord University
Bobigny, France

cover img faculity

Toby Eyre, MBChB, MD

Honorary Senior Lecturer
Hematology and Cancer
University of Oxford
Consultant Hematologist
Department of Hematology
Hematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom

cover img faculity

Marco Ladetto, MD

Associate Professor in hematology
University of Eastern Piedmont
Director of SCDU Hematology Division
AO SS Antonio E Biagio e Cesare Arrigo
Alessandria, Piedmont, Italy

cover img faculity

Ana Marin-Niebla, MD, PhD

Hematology Consultant, Lymphoma Unit
Vall d'Hebron Institute of Oncology, Hematology Department
Hospital Universitario Vall d'Hebron
Barcelona, Spain

cover img faculity

Carsten Niemann, MD

Consultant in Hematology: Internal Medicine
Rigshospitalet, Copenhagen University Hospital
Department of Hematology
Copenhagen, Denmark

cover img faculity

Guilherme Perini, MD

Head
Center of Excellence in Lymphoma
Hospital Israelita Albert Einstein
Sao Paulo, Brazil

cover img faculity

Stephan Stilgenbauer, MD

Medical Director Comprehensive Cancer Center Ulm
Head, Early Clinical Trials Unit
Head, Division of CLL Dept. of Internal Medicine III
University Medical Center
Ulm University
Ulm, Germany

cover img faculity

Alessandra Tedeschi, MD

Director of Indolent Lymphoproliferative Disorders
Department of Hematology
Niguarda Cancer Center
Niguarda Hospital
Milan, Italy

cover img faculity

Max Topp, MD

Professor
Head of Hematology
Department of Hematology
Universitätsklinikum Würzburg
Würzburg, Germany

cover img faculity

Pier Luigi Zinzani, MD, PhD

Professor of Hematology
Head of Lymphoma and Chronic Lymphoproliferative Syndromes Unit
Institute of Hematology “L. e A. Seràgnoli”
University of Bologna
Bologna, Italy

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.